TickerFactsScreenerDevelopers

Lyell Immunopharma, Inc. (LYEL) — EPS (Diluted)

Annual figures by fiscal year, from SEC filings.

2019: $-24.042020: $-15.692021: $-1.842022: $-0.742023: $-18.702024: $-26.232025: $-16.06$-16.06
2019EPS (Diluted) (USD/shares)2025
Fiscal YearEPS (Diluted)Change YoY
2025$-16.06+38.8%
2024$-26.23-40.3%
2023$-18.70-2427.0%
2022$-0.74+59.8%
2021$-1.84+88.3%
2020$-15.69+34.7%
2019$-24.04—